Page last updated: 2024-08-23

cabergoline and Erectile Dysfunction

cabergoline has been researched along with Erectile Dysfunction in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's3 (42.86)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akirov, A; Barzilay-Yoseph, L; Eizenberg, Y; Fraenkel, M; Friedrich, I; Herzberg, D; Hirsch, D; Ishay, A; Livner, A; Manisterski, Y; Masri, H; Robenshtok, E; Shimon, I; Tsvetov, G; Yoel, U1
Chatterjee, S; Das, A; Maiti, A1
Anand, KS; Dhikav, V1
Altomare, M; Colosimo, C; Corsello, SM; Lovicu, RM; Migneco, MG; Rota, CA; Ubertini, G1
Colao, A; De Rosa, M; Di Somma, C; Lombardi, G; Orio, F; Tauchmanova', L; Vitale, G; Zarrilli, S1
Christ, ER; Jenni, S; Seiler, R; Stettler, C1
Coppola, A; Cuomo, MA1

Reviews

1 review(s) available for cabergoline and Erectile Dysfunction

ArticleYear
[Prolactinoma in the male. Physiopathological, clinical, and therapeutic features].
    Minerva endocrinologica, 1998, Volume: 23, Issue:1

    Topics: Cabergoline; Cranial Irradiation; Dopamine Agonists; Erectile Dysfunction; Ergolines; Galactorrhea; Gynecomastia; Humans; Hyperprolactinemia; Hypophysectomy; Infertility, Male; Libido; Male; Pituitary Neoplasms; Prolactinoma; Treatment Outcome

1998

Trials

1 trial(s) available for cabergoline and Erectile Dysfunction

ArticleYear
Six months of treatment with cabergoline restores sexual potency in hyperprolactinemic males: an open longitudinal study monitoring nocturnal penile tumescence.
    The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:2

    Topics: Adult; Cabergoline; Case-Control Studies; Circadian Rhythm; Dopamine Agonists; Drug Administration Schedule; Erectile Dysfunction; Ergolines; Humans; Hyperprolactinemia; Longitudinal Studies; Male; Middle Aged; Penile Erection; Testosterone; Treatment Outcome

2004

Other Studies

5 other study(ies) available for cabergoline and Erectile Dysfunction

ArticleYear
Hyperprolactinemia diagnosis in elderly men: a cohort of 28 patients over 65 years.
    Endocrine, 2019, Volume: 65, Issue:3

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cabergoline; Cohort Studies; Erectile Dysfunction; Humans; Hyperprolactinemia; Israel; Male; Osteoporosis; Prolactin; Prolactinoma; Retrospective Studies; Testosterone; Treatment Outcome

2019
A man with breast discharge and headache.
    European journal of internal medicine, 2016, Volume: 29

    Topics: Adult; Brain; Cabergoline; Dopamine Agonists; Erectile Dysfunction; Ergolines; Headache; Humans; Magnetic Resonance Imaging; Male; Nipple Discharge; Pituitary Neoplasms; Prolactinoma

2016
Hyperprolactinemia: an unusual cause of erectile dysfunction.
    Archives of sexual behavior, 2013, Volume: 42, Issue:3

    Topics: Adenoma; Adult; Cabergoline; Dopamine Agonists; Erectile Dysfunction; Ergolines; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Treatment Outcome

2013
Giant prolactinomas in men: efficacy of cabergoline treatment.
    Clinical endocrinology, 2003, Volume: 58, Issue:5

    Topics: Adrenal Glands; Adult; Aged; Antineoplastic Agents; Cabergoline; Erectile Dysfunction; Ergolines; Humans; Hypothyroidism; Libido; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Vision Disorders

2003
[Simultaneous defect of visual fields and loss of libido--a coincidence?].
    Praxis, 2006, Dec-06, Volume: 95, Issue:49

    Topics: Cabergoline; Diagnosis, Differential; Dopamine Agonists; Erectile Dysfunction; Ergolines; Humans; Hyperprolactinemia; Hypogonadism; Libido; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Compression Syndromes; Optic Nerve Diseases; Pituitary Neoplasms; Prolactinoma; Visual Fields

2006